Stock to Watch: Zoetis (ZTS) Parsippany, NJ-based Zoetis Inc. came into existence following Pfizer’s decision to spin off its animal health business. The entity started trading on the NYSE on Feb 1, 2013, under the name Zoetis. The company is a leader in the animal health space, which...
The bad news is that $15.35 divided into Lilly's $837 share price gives the stock a staggering54.5 current-year P/E-- which is a lot for a pharma stock. (Pandemic era darlingPfizerfor example, costs less than 12 times forward earnings.) Granted, so long as Lilly keeps growing earnings...
What’s Next: Albert Bourla, CEO of vaccine giant Pfizer, isn’t worried about Trump administration vaccine skeptics such as Robert F. Kennedy Jr., named to run the federal health bureaucracy. Bourla, who said opportunities outweigh risks, has met with Trump and sees a chance to work with...
power to investors create free account about premium free newsletters home stock analysis stock ideas market outlook investing strategy long ideas ipo analysis editor's picks cryptocurrency market news top market news notable calls on the move earnings news energy stock news tech stoc...
First, a little Index 101: Formally created in 1957, the S&P 500 often shares headlines – and solid alignment – with theDow Jones industrial average, which dates to 1896. While the Dow only contains 30 stocks, including Exxon Mobil Corp. (XOM), Boeing Co. (BA) and Pfizer (PFE), it...
Equal-weighted ETFs such as theInvesco S&P 500 Equal Weight ETF (RSP), which is the largest fund in its category, minimize single stock risk. That’s a potential selling point for investors at a time when growth and technology stocks are weighing on the broader market. ...
Chinese companies were very dependent on US chips at the time. So they started stockpiling massive numbers of chips, because that’s what allowed them to stay in business. So the sanctions are coming six months from now, they’ll be in effect, you can’t buy Intel chips. ...
C.S. reports grants and personal fees from Bristol Myers Squibb, AstraZeneca, Boehringer-Ingelheim, Roche-Ventana, personal fees from Pfizer, grants from Ono Pharmaceutical, Personalis, grants, personal fees and other support from GRAIL, other support from AstraZeneca and GRAIL, personal fees and ...
Comment on the Pfizer-Allergan merger from the standpoint of oligopoly theory. Discuss competitive strategy differences between a fragmented and a consolidated industry. Successful firms such as Microsoft and Apple have consistently delivered strong st...
Pfizer: "Well, Pfizer's kind of sitting there. They need to do a deal, they need to split up or buy someone. They should buyBristol-Myers [Squibb]. Then we'd have everything work out." Arconic Inc.: "Well, we're telling club members of [Cramer's charitable trust] ActionAlertsPlus...